Explore the advancements in targeted therapies for non-Hodgkin lymphoma (NHL) in this 40-minute lecture. Delve into the growing array of treatment options that offer reduced side effects compared to traditional methods. Gain insights into the crucial laboratory techniques used for diagnosing NHL and identifying potential targets for therapy. Understand the importance of clinical trials in determining the optimal application of these targeted treatments. Learn about the evolving landscape of NHL management and how it's shaping the future of patient care in hematology.